Financhill
Back

Sarepta Therapeutics, Inc. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Sarepta Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 20.03 Buy
20-day SMA: 18.6 Buy
50-day SMA: 20.56 Buy
200-day SMA: 37.1 Sell
8-day EMA: 20.15 Buy
20-day EMA: 19.64 Buy
50-day EMA: 20.05 Buy
200-day EMA: 40.01 Sell

Sarepta Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.08 Buy
Relative Strength Index (14 RSI): 58.53 Buy
Chaikin Money Flow: 3222661 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

Sarepta Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Sarepta Therapeutics, Inc. Stock

Is Sarepta Therapeutics, Inc. Stock a Buy?

SRPT Technical Analysis vs Fundamental Analysis

Sell
48
Sarepta Therapeutics, Inc. (SRPT) is a Sell

Is Sarepta Therapeutics, Inc. a Buy or a Sell?

Sarepta Therapeutics, Inc. Stock Info

Market Cap:
2.3B
Price in USD:
21.84
Share Volume:
3.5M

Sarepta Therapeutics, Inc. 52-Week Range

52-Week High:
131.31
52-Week Low:
10.42
Sell
48
Sarepta Therapeutics, Inc. (SRPT) is a Sell

Sarepta Therapeutics, Inc. Share Price Forecast

Is Sarepta Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Sarepta Therapeutics, Inc.

Is Sarepta Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $1.60 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.03 per share, and an increase next year of $5.31 per share.

Technical Analysis of Sarepta Therapeutics, Inc.

Should I short Sarepta Therapeutics, Inc. stock?

* Sarepta Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.